Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 546 results found. Search for [ All India Institute of Medical Sciences ]

Results 20 to 40 of 546
PTI
August 25, 2020
Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the Covid-19 vaccine candidate, developed by the University of Oxford


BusinessToday.In
August 23, 2020
Initially, the ICMR vaccine portal will disseminate information on coronavirus vaccine in India. However, with time, data available for all the vaccines will be added to the portal


BusinessToday.In
August 22, 2020
Bharat Biotech has received nod to conduct the Phase I and II clinical trial of its COVID-19 vaccine 'Covaxin' through intradermal route, which is just under the skin


BusinessToday.In
August 22, 2020
According to locksmith Shaikh, he was called to Sushant's flat to break the lock of the bedroom. The locksmith said, \" It was a computerised lock. I broke it with a knife and a hammer\"


PTI
August 22, 2020
The Central Bureau of Investigation (CBI) approached the forensic department of the All India Institute of Medical Sciences on Friday for its medico-legal opinion in the case


PTI
August 19, 2020
In addition to the ventilators, USAID is funding a package of support that includes warranties and additional supplies required to operate these machines, such as tubes, filters and other necessary components


BusinessToday.In
New Delhi, August 13, 2020
One of India's leading medical experts, Dr Randeep Guleria, Director of the New Delhi-based All India Institute of Medical Sciences (AIIMS), has advised caution with regard to 'Sputnik V', the coronavirus vaccine for which Russia has granted regulatory approval. The vaccine raises concerns among some experts about the speed of its approval. Watch the video for more.


BusinessToday.In
August 3, 2020
A team of doctors led by AIIMS, Delhi Director Dr Randeep Guleria, will visit Medanta Hospital in Gurugram to oversee Shah's line of treatment


BusinessToday.In
July 28, 2020
Coronavirus vaccine news: Serum Institute of India CEO Adar Poonawalla had earlier stated that the company would reserve 50 per cent of the vaccine doses for use in India


PTI
July 28, 2020
Covaxin is the first indigenous vaccine developed by India against Covid-19 and is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune.


BusinessToday.In
July 25, 2020
Coronavirus vaccine news: Serum Institute of India will start trials of the Oxford University-AstraZeneca COVID-19 vaccine by the end of August. Up to 5,000 Indian volunteers would be included in the tests


BusinessToday.In
July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles


BusinessToday.In
July 23, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021


BusinessToday.In
New Delhi, July 22, 2020
Covaxin, an experimental novel coronavirus vaccine developed by Hyderabad-based Bharat Biotech, has begun human trials at New Delhi's All India Institute of Medical Sciences this week. AIIMS-New Delhi is one the 12 sites chosen by the Indian Council of Medical Research, which is a collaborator on the Covaxin novel coronavirus vaccine project, for conducting human trials. How much time will this vaccine take, how many trials will take place and where. Watch the video to know more.Govt warns 59 Chinese apps of serious action if found operating despite ban


BusinessToday.In
July 22, 2020
Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals


BusinessToday.In
July 20, 2020
COVAXIN is the first indigenous coronavirus vaccine, being developed by Hyderabad-based Bharat Biotech and Indian Council of Medical Research (ICMR). AIIMS, Delhi is one of the 12 facilities shortlisted by ICMR for conducting clinical trials of Covaxin


BusinessToday.In
July 20, 2020
Coronavirus vacciine update: Trials on 1,077 people showed that the vaccine, officially known as AZD1222, led to generation of antibodies and white blood cells that can fight coronavirus


BusinessToday.In
July 20, 2020
Covaxin is being jointly developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology and is India's first indigenously developed COVID-19 vaccine candidate


BusinessToday.In
July 19, 2020
Coronavirus vaccine news update: Only 100 participants out of the 375 volunteers would be picked for the first and second phases. The rest would participate in trials at other sites


PTI
July 18, 2020
Prof. K Srinath Reddy, who formerly headed the Department of Cardiology at the All India Institute of Medical Sciences, said up to the second phase of lockdown, control measures were very strict as India tried to contain the spread


PAGES 2 OF 28  12345